Generic GLP-1 receptor agonists in India: an opportunity to close the cardiovascular evidence gap

The Lancet Regional Health - Southeast Asia · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles